CLINICAL COURSE AND TREATMENT CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE. UOC. 2026;(11). Accessed September 12, 2026. https://openconf.uz/conf/article/view/376